$17.02 -0.33 (%) Biodelivery Sciences International Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Stocks Sag In Light Trade; Taser Bolts Higher, Gilead Dips

    IBD | Sep. 5, 2014 | 10:33AM EST
  2. Companhia Paranaense Leads Energy Sector; Peabody Drops Over 14%

    Benzinga | Jul. 7, 2014 | 15:28PM EST
  3. Silicon Motion Surges On Strong Q2 Outlook; GT Advanced Shares Slide

    Benzinga | Jul. 7, 2014 | 13:05PM EST
  4. Benzinga's Volume Movers

    Benzinga | Jul. 7, 2014 | 10:17AM EST
  5. Markets Open Lower; ADM To Acquire Wild Flavors For $3 Billion

    Benzinga | Jul. 7, 2014 | 10:13AM EST
  6. Stocks Hitting 52-Week Highs

    Benzinga | Jul. 7, 2014 | 10:05AM EST
  7. Morning Market Movers

    Benzinga | Jul. 7, 2014 | 09:37AM EST
  8. Stock Futures Sag Early Monday; King Digital Leans Higher

    IBD | Jul. 7, 2014 | 08:59AM EST
  9. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 7, 2014 | 08:08AM EST
  10. Benzinga's Volume Movers

    Benzinga | Jun. 12, 2014 | 10:18AM EST
  11. 3 Stock To Consider Trading Before They Make Headlines

    Benzinga | Jun. 6, 2014 | 06:51AM EST
  12. BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine

    Benzinga | Apr. 3, 2014 | 07:13AM EST
  13. UPDATE: Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain

    Benzinga | Jan. 23, 2014 | 16:31PM EST
  14. Endo, BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Program

    Benzinga | Sep. 4, 2013 | 06:31AM EST
  15. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2013 Financials

    Benzinga | Aug. 9, 2013 | 16:08PM EST
  16. BioDelivery Sciences Announces Taiwan Regulatory Approval of ONSOLIS

    Benzinga | Jul. 29, 2013 | 07:03AM EST
  17. UPDATE: Piper Jaffray Initiates Coverage on BioDelivery Sciences International with Neutral Rating, $5 PT

    Benzinga | Jan. 4, 2013 | 03:07AM EST
  18. BioDelivery Sciences International, Inc. (BDSI) CEO Mark A Sirgo buys 4,975 Shares

    GuruFocus | Dec. 21, 2012 | 10:36AM EST
  19. BioDelivery Sciences Announces $40M in Financing Commitments

    Benzinga | Nov. 28, 2012 | 00:27AM EST
  20. BioDelivery Sciences International Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 9, 2012 | 01:33AM EST
  21. Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX

    GuruFocus | Jul. 17, 2012 | 07:18AM EST
  22. BioDelivery Sciences International Inc. (BDSI) CFO James A Mcnulty sells 108,798 Shares

    GuruFocus | Jul. 10, 2012 | 14:18PM EST
  23. Disney, Raytheon and Other Avenger Picks for a Heroic Portfolio

    Benzinga | May. 18, 2012 | 00:40AM EST
  24. UPDATE: Ladenburg Thalmann Maintains Buy Rating, Raises PT for BioDelivery Sciences International

    Benzinga | May. 14, 2012 | 05:16AM EST
  25. Financial Breakfast: Morning News Summary for February 22, 2012

    Benzinga | Feb. 22, 2012 | 00:33AM EST
  26. Benzinga's Microcap Movers for Thursday February 16, 2012

    Benzinga | Feb. 16, 2012 | 14:21PM EST
  27. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals

    Benzinga | Feb. 16, 2012 | 01:46AM EST
  28. Shares of BioDelivery Sciences Are Up 13% After Licensing Agreement Announcement

    Benzinga | Jan. 12, 2012 | 03:45AM EST
  29. Benzinga's Microcap Movers for Friday January 6, 2012

    Benzinga | Jan. 8, 2012 | 01:53AM EST
  30. BioDelivery Sciences Popping 160% On License and Development Agreement

    Benzinga | Jan. 6, 2012 | 01:41AM EST
  31. BioDelivery Sciences International Responds to Approval of Class-Wide REMS for All Transmucosal Fentanyl Products

    Benzinga | Dec. 29, 2011 | 07:39AM EST
  32. BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study

    Benzinga | Dec. 20, 2011 | 09:23AM EST
Trading Center